RCD advises AlbaJuna Therapeutics, an IrsiCaixa spin-off, on the inflow of capital that will fund the development of antibodies against HIV

by RCD

RCD – Rousaud Costas Duran has advised AlbaJuna Therapeutics, a spin-off from the IrsiCaixa AIDS Research Institute, on the investment of €3.75M by the pharmaceutical company Grifols, which will s...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Grupo ONEtoONE desembarca con su fondo d...

by ONEtoONE Corporate Finance

ONEtoONE Asset Management ha realizado su quinta inversión fuera de n...

Photos Stream